Olopatadine

CHEMBL1189432 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

337.4 g/mol

LogP

1.5

Phase

4

An antihistamine and mast cell stabilizer treating eye allergies, nasal allergies, and atopic dermatitis.

Molekularmasse

337,4000 g/mol

LogP

1,50

TPSA

49,80 Å²

Lipinski-Regel der Fünf

Bestanden

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21

InChI

InChI=1S/C21H23NO3/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24)/b18-8-

Molecular Formula

C21H23NO3

HBD / HBA

1 / 4

Rotierbare Bindungen

5

Schwere Atome

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

An antihistamine and mast cell stabilizer treating eye allergies, nasal allergies, and atopic dermatitis.

Yes, Olopatadine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1189432. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5281071. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Olopatadine auf PillFYI

Struktur

Schnelldaten

Formel: C21H23NO3
Synonyme: 23

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.